Search Results
Nov 07, 2025, 08:37 ET Hanyang University Researchers Develop of Novel High-Resolution Mechanoluminescent Platform Technology
Advanced Materials. In this study, the team coated the conjugated polymer poly(9,9-dioctylfluorene-alt-benzothiadiazole) (F8BT) onto ZnS:Cu to selectively suppress emission below 490 nm, narrowing the full width at half maximum from 94 nm to 55 nm.
More news about: Hanyang University
Nov 07, 2025, 08:31 ET MetaVia Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting® 2025
therapies. In addition to its glycemic effects, vanoglipel significantly decreased plasma ALT levels in subjects with baseline ALT between 40 and 200 U/L. The reduction in ALT was not further enhanced by co-administration with a DPP4 inhibitor, suggesting that vanoglipel monotherapy
More news about: MetaVia Inc.
Nov 06, 2025, 10:11 ET Sally Beauty Invites Consumers to Celebrate Beauty at Home and Skip the Salon with New Holiday Campaign
ALT., Good Chemistry, and Solinotes launching online throughout November, just in time for the holidays. The
More news about: SALLY BEAUTY HOLDINGS
Nov 06, 2025, 08:58 ET Huawei, Dijital Dönüşümü Hızlandırmak için KOBİ'lere "4+10+N" Zeka Çözümleri Sunuyor
ve büyümeyi desteklemek için özel olarak tasarlanmış çözümler arıyor. Geçmişte, kurulumcular bu çözümleri genellikle oldukça verimsiz olan karmaşık alt yüklenici modelleri kullanarak sağlıyordu. Huawei, pazarın bu sorunlu noktasını ele almak için dağıtım işini yeniden düzenledi
More news about: Huawei Europe
Nov 04, 2025, 03:00 ET PPHE Hotel Group Implements Oracle OPERA Cloud to Improve Operations and Drive Innovation
is dedicated to delivering a differentiated and unique experience to its guests that can only be achieved with a modern, secure platform," said Alex Alt, executive vice president and general manager, Oracle Commercial Cloud Applications. "With OPERA Cloud, PPHE will have the agility to continually innovate,
More news about: Oracle
Nov 03, 2025, 09:05 ET Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
constipation/fatigue (25% each), and creatinine/alanine aminotransferase (ALT) increased (21.9% each), the majority being Grade 1/2. One (1) dose limiting toxicity (DLT) (Grade 4 aspartate aminotransferase (AST) increase/Grade 3 ALT increase) was reported in the 750 mg dose group.
More news about: Rigel Pharmaceuticals, Inc.
Nov 03, 2025, 08:08 ET Eisai Demonstrates Commitment to Advanced Endometrial Cancer Care at IGCS 2025
erythrodysesthesia (11%), nausea (9%), stomatitis (9%), musculoskeletal pain (8%), rash (8%), increased lipase (7%), abdominal pain (6%), vomiting (6%), increased ALT (5%), and increased amylase (5%). In RCC, the most common adverse reactions (≥30%) observed in LENVIMA + everolimus–treated patients
More news about: Eisai Inc.
Nov 02, 2025, 02:33 ET DaVinci Gourmet Barista Craft Championship 2026: "Espresso Your Flavour" - Başvurular Başladı
noktası olmaya devam etmesi sağlanmıştır. Dijital turdan geçen baristalar, yüksek enerjili yüz yüze Ulusal Finallerde, ardından Alt Bölge Finallerinde ve son olarak Mayıs 2026'da Vietnam'da düzenlenecek prestijli Küresel Finalde yarışacaklar. Her aşamada, üstün yetenekler nakit ödüller,
More news about: Kerry Group
Oct 30, 2025, 07:00 ET Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update
In ASPEN, there was an increase from baseline in average ALT, AST, and alkaline phosphatase levels at all time points from Week 4 through Week 56 in both BRINSUPRI 10 mg and 25 mg arms compared to placebo. The incidence of ALT >3X upper limit of normal (ULN) was 0%, 1.2%, and 0.9%; the incidence
More news about: Insmed Incorporated
Oct 29, 2025, 08:35 ET "67": Dictionary.com's 2025 Word of the Year--What Does it Mean?
a homemaker as a primary occupation and adheres to or embodies traditional femininity and female gender roles, often associated with conservative or alt-right political values. From consistently
More news about: IXL Learning
Oct 28, 2025, 19:02 ET BrowserStack führt einen KI-Agenten zur Problemerkennung ein, der menschliche Intelligenz in die Barrierefreiheitstests einbringt
Automatisch zwischen dekorativen, funktionalen und Textbildern unterscheiden. Komplexe Bilder, die beschreibenden Alt-Text erfordern, mithilfe von Kontextanalysen automatisch erkennen. Überprüfen, ob die Fokusreihenfolge des Screenreaders einer
More news about: BrowserStack
Oct 28, 2025, 16:45 ET FIVE-TIME GRAMMY-NOMINATED SINGER-SONGWRITER KEHLANI, GRAMMY-WINNING GLOBAL RECORDING ARTIST KALI UCHIS, AND KPOP DEMON HUNTERS' LEAD VOCALIST EJAE TO BE HONORED AT 2025 ASCAP WOMEN BEHIND THE MUSIC
artistGlobal superstar and Grammy-winning recording artist Kali Uchis has been hailed as a rare talent since she emerged. With artful forays into R&B, alt-pop, reggaeton and Latin strains, she has released several of the most lauded albums of the past decade including 2023's Red Moon in Venus, which
More news about: ASCAP - American Society of Composers, Authors and Publishers
Oct 28, 2025, 12:18 ET ADCOLOR Reveals All-Star Lineup of Speakers, Honorees, and Performers for ADCOLOR 2025
'CTRL + ALT + LIFT,' which calls on the community to reclaim their narratives, explore new ways forward, and lift one another toward lasting impact. "This year, we're taking the reins," said Tiffany R. Warren, Founder and President of ADCOLOR. "CTRL + ALT + LIFT
More news about: ADCOLOR
Oct 28, 2025, 09:34 ET BrowserStack Launches Issue Detection AI Agent That Brings Human Intelligence to Accessibility Testing
Automatically differentiate between decorative, functional, and images of text. Auto-detect complex images requiring descriptive alt-text with contextual analysis. Verify that the screen-reader focus order follows a meaningful reading sequence and more.
More news about: BrowserStack
Oct 28, 2025, 09:21 ET BrowserStack Launches Issue Detection AI Agent That Brings Human Intelligence to Accessibility Testing
Automatically differentiate between decorative, functional, and images of text. Auto-detect complex images requiring descriptive alt-text with contextual analysis. Verify that the screen-reader focus order follows a meaningful reading sequence and more.
More news about: BrowserStack
Oct 28, 2025, 08:00 ET Enhanced Weathering Alliance Ramps up Coalition Efforts to Scale Carbon Removal
Barclays and Microsoft. The coalition includes leading enhanced weathering companies and organizations: Alt Carbon, Carbonfuture, Carbon Drawdown Initiative, Carbony, Eion, Flux, InPlanet, Mati, The Rock Flour Company, Silica, Terradot, UNDO, and ZeroEx. Observers
More news about: Carbon Business Council
Oct 28, 2025, 07:03 ET Answear.com Modernizes its Retail Planning Processes with Oracle Cloud
Oracle's cloud-based retail platform and AI Foundation, Answear.com can strengthen its move from product-centric to customer-focused planning," said Alex Alt, executive vice president and general manager, Oracle Consumer Industries. "This transformation can help drive more profitable inventory investments
More news about: Oracle
Oct 27, 2025, 13:00 ET Lilly Drafts Shaquille O'Neal to Raise Awareness for Moderate-to-Severe Obstructive Sleep Apnea
Chang JL, Goldberg AN, Alt JA, et al. International consensus statement on obstructive sleep apnea. Int Forum Allergy Rhinol. 2023;13(7):1061-1482.
More news about: Eli Lilly and Company
Oct 21, 2025, 19:30 ET PADCEV™ (enfortumab vedotin-ejfv) Plus KEYTRUDA® (pembrolizumab) sBLA Granted FDA Priority Review for Treatment of Certain Patients with Muscle-Invasive Bladder Cancer
aminotransferase (AST), increased creatinine, rash, increased glucose, PN, increased lipase, decreased lymphocytes, increased alanine aminotransferase (ALT), decreased hemoglobin, fatigue, decreased sodium, decreased phosphate, decreased albumin, pruritus, diarrhea, alopecia, decreased weight, decreased
More news about: Astellas Pharma Inc.
Oct 20, 2025, 16:10 ET W. R. Berkley Corporation Reports Third Quarter 2025 Results
Residential - Alt A
More news about: W.R. BERKLEY CORPORATION
Oct 20, 2025, 12:30 ET iVANKY Introduces FusionDock Max 2: The First MacBook Dock for Thunderbolt 5 with Native Triple-Display Support
perform under heavy load." FusionDock Max 2 introduces a dual-chip architecture that pairs a Thunderbolt 5 controller with a DP-Alt chip, allowing users to connect up to two 6K displays and one 4K display natively — a first for MacBook docks. It also unlocks up to 120 Gbps of bandwidth,
More news about: iVANKY
Oct 20, 2025, 08:37 ET Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch
Hepatotoxicity LYMPHIR can cause hepatotoxicity. In the pooled safety population, elevated ALT occurred in 70% of patients, with Grade 3 ALT occurring in 22%; elevated AST occurred in 64% of patients, with Grade 3 AST elevation occurring in 9%. For Grade 3 events, median
More news about: Citius Oncology, Inc.
Oct 19, 2025, 10:30 ET Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer
pruritus (24%), and nausea (21%). The most common Grade 3 or 4 laboratory abnormalities (≥2%) were decreased albumin (8%), decreased sodium (7%), increased ALT (7%), decreased potassium (5%), decreased hemoglobin (3.8%), increased AST (3.8%), increased GGT (2.6%), and increased magnesium (2.6%).
More news about: Johnson & Johnson
Oct 18, 2025, 10:30 ET PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer
aminotransferase (AST), increased creatinine, rash, increased glucose, PN, increased lipase, decreased lymphocytes, increased alanine aminotransferase (ALT), decreased hemoglobin, fatigue, decreased sodium, decreased phosphate, decreased albumin, pruritus, diarrhea, alopecia, decreased weight, decreased
More news about: Astellas Pharma Inc.
Oct 17, 2025, 08:00 ET Lilly's Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment
increases in alanine aminotransferase (ALT) (2 to 6%) and aspartate aminotransferase (AST) (2 to 3%) were reported in patients receiving Verzenio. Across three clinical trials in 3559 patients (monarchE, MONARCH 2, MONARCH 3), the median time to onset of Grade ≥3 ALT increases ranged from 57 to 87
More news about: Eli Lilly and Company